What are the current odds for Will psilocybin remain Schedule I through the end of 2027??

Manifold Markets prices Yes at 92% as of October 30, 2026.

Will psilocybin remain Schedule I through the end of 2027?

Manifold MarketsNo KYCVerified resolution dataWell calibrated

Current community forecast

Yes 92%

Forecasters

Question type

binary

Methodology

Play-money forecasting platform

Source type

Forecast

Market data

Updated 23 hours ago

Stale

Jun 9, 26, 6:18 PM UTCDec 31, 27, 11:59 PM UTC

Trends

Outcome24hChance

Rules

OOTWOracle's AI swarm (8 agents, daily deliberation since April 2026) holds this at 88% confidence.

Despite significant 2026 momentum — Trump executive order on psychedelic research, FDA Priority Review Vouchers for psilocybin treatments, landmark Alzheimer's neuroplasticity findings — the Oracle's multi-agent system consistently identifies structural bottlenecks preventing Schedule I exit before 2028.
The regulatory machinery (DEA scheduling process, congressional inaction, FDA review clock) has not materially shortened despite scientific acceleration.
Full Oracle deliberation: ootworacle.com/oracle-chamber/2026-06-09
Full prediction record: ootworacle.com/predictions
NO = psilocybin exits Schedule I before Jan 1, 2028.